Alert: 5 Tickers Trending Now

Names Inside Dear Reader, According to our research, there are a few trending companies that have recently received buy ratings and showing a combination of positive investor sentiment, news headlines and blog buzz. With that said, we are not recommending buying these names but we are adding them to our stock watchlist. We will continue to monitor companies to see if the momentum continues. --------------------------------------------------------------- Sponsor [Better Than Oil Stocks]( best way to profit from energy is NOT a stock... Rather, it's this little-known alternative investment. [CLICK HERE TO FIND OUT MORE]( --------------------------------------------------------------- [AstraZeneca, AZN]( Summary: AstraZeneca plc, is one of the largest biopharmaceutical companies in the world. AstraZeneca's business can be broken down into separate lines based on therapeutic classes. These include cardiovascular, respiratory, immunology, oncology, rare diseases and other. Andrew Berens analyst at SVB Securities reiterates coverage on [AstraZeneca (AZN)]( with a Buy rating and has set a price target of n/a. [TipRanks.com]( reports that [AstraZeneca]( has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $136.32. In addition, TradingView issued a Strong Buy rating for [AZN]( over the next month, Barchart.com has a Strong buy rating and Yahoo! Finance has a Bullish short-term outlook. [For the chart and additional details on AZN, please click here >>]( --------------------------------------------------------------- [Linde, LIN]( Summary: New Linde plc. is an industrial gases and engineering company. It serves chemicals & energy, food & beverage, electronics, healthcare, manufacturing, metals and mining market. New Linde plc., formerly known as LINDE PLC, is based in WOKING, UK. Geoff Haire analyst at UBS reiterates coverage on [Linde (LIN)]( with a Buy rating and has set a price target of $ 410. [TipRanks.com]( reports that [Linde]( has 17 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $381.01. In addition, TradingView issued a Buy rating for [LIN]( over the next month, Barchart.com has a Strong buy rating and Yahoo! Finance has a Bullish short-term outlook. [For the chart and additional details on LIN, please click here >>]( --------------------------------------------------------------- Sponsor [Apple to SHOCK Emerging $46T Industry]( Valley venture capitalist Luke Lango says this little-known Apple project could be 10X bigger than the iPhone, MacBook, and iPad COMBINED! Investing in Apple today would be a smart move... but he’s discovered a bigger opportunity lying under Wall Street’s radar -one that could give early investors a shot at 40X gains! [Click here for more details.]( --------------------------------------------------------------- [CVS Health, CVS]( Summary: CVS Health Corporation is a pharmacy innovation company. Its offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. Michael Cherny analyst at Bank of America Securities reiterates coverage on [CVS Health (CVS)]( with a Buy rating and has set a price target of $ 104. [TipRanks.com]( reports that [CVS Health]( has 9 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $114.89. In addition, TradingView issued a Sell rating for [CVS]( over the next month, Barchart.com has a Strong sell rating and Yahoo! Finance has a Bullish short-term outlook. [For the chart and additional details on CVS, please click here >>]( --------------------------------------------------------------- [TJX Companies, TJX]( Summary: The TJX Companies, Inc. is a leading off-price retailer of apparel and home fashions in the U.S. and worldwide. The company's broad range of assortments at varying prices helps it to reach out to a broad range of consumers. In addition to these, The TJX Companies tries to attract consumers through rapid turn of inventories. Ebrahim Poonawala analyst at Bank of America Securities reiterates coverage on [TJX Companies (TJX)]( with a Buy rating and has set a price target of $ 94. [TipRanks.com]( reports that [TJX Companies]( has 11 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $90.73. In addition, TradingView issued a Buy rating for [TJX]( over the next month, Barchart.com has a buy rating and Yahoo! Finance has a Bullish short-term outlook. [For the chart and additional details on TJX, please click here >>]( --------------------------------------------------------------- Sponsor [The Fed's Boldest Mover Ever...]( national currency “reset” is coming to America. With every dollar soon under Fed control, how will FedNow impact your day-to-day expenses?... your paycheck?... your social security?... your investments? [Don’t wait to find out.]( --------------------------------------------------------------- [Synopsys, SNPS]( Summary: Synopsys is a vendor of electronic design automation (EDA) software to the semiconductor and electronics industries. The company offers a full suite of products used in the logic synthesis and functional verification phases of chip design, including a broad array of reusable design building blocks. [Gary Mobley analyst at Wells Fargo reiterates coverage on]( (SNPS)]( with a Buy rating and has set a price target of $ 410. [TipRanks.com]( reports that [Synopsys]( has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $431.25. In addition, TradingView issued a Buy rating for [SNPS]( over the next month, Barchart.com has a Strong buy rating and Yahoo! Finance has a Bullish short-term outlook. [For the chart and additional details on SNPS, please click here >>]( --------------------------------------------------------------- Sponsor [A play in AI with 100X potential]( Investors can get in for around 38 cents right now. [Watch what this new tech can do.]( --------------------------------------------------------------- Remember, securities are volatile, so please do your own research. One resource you need to consider using [Tipranks.com]( where as a premium member you get access to all buy ratings, price targets and insider trading signals. [Get more from TipRanks.com here >>]( Thanks for reading! The Editor, [wallstreetanalystpress.com]( --------------------------------------------------------------- Sponsor [Famous Investor's 2023 Warning Already Coming True]( warning from man who predicted Lehman Crash is playing out perfectly... And it could make some Americans rich, while leaving others behind. --------------------------------------------------------------- [To Cancel Your Free Subscription, click here.]( WallStreetAnalystPress.com Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. Content marked as "Ad," "Special" or "Sponsor" may be a third party advertisements where the advertiser is paying per click, per lead or per sale and are not endorsed or warranted by our staff or company. Sandpiper Marketing Group, LLC is also being compensated by Summit Publishing Group and Investing Trends up to three dollars per click and may exceed twelve thousand, five hundred dollars per week for placement of specific advertisements contained in this newsletter. Sandpiper Marketing Group, LLC and its principles do not own any of the stocks mentioned in this email or in the article that this email links to. Please see the disclaimer on the advertiser's website for additional information, including their relationship with any mentioned security. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. This newsletter may contain information regarding investment ideas and third-party ratings regarding specific securities. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. Sandpiper Marketing Group, LLC nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from Sandpiper Marketing Group, LLC to buy or sell any security. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. By opening this email or clicking any links contained, you are reconfirming your opt-in status. You can unsubscribe at any time by clicking the link below in the footer. This is part of your free subscription to WallStreetAnalystPress. WallStreetAnalystPress.com part of Sandpiper Marketing Group, LLC | 1519 Mecklenburg Hwy Unit 407 | Mt. Mourne | North Carolina | 28123 [UNSUBSCRIBE](